Terns Pharmaceuticals Stock Forecast - Triple Exponential Smoothing
| TERN Stock | USD 34.45 0.12 0.35% |
Terns Stock outlook is based on your current time horizon. Although Terns Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Terns Pharmaceuticals' systematic risk associated with finding meaningful patterns of Terns Pharmaceuticals fundamentals over time.
As of today, The relative strength index (RSI) of Terns Pharmaceuticals' share price is at 55. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Terns Pharmaceuticals, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (1.09) | EPS Estimate Next Year (1.21) | Wall Street Target Price 58.125 | EPS Estimate Current Quarter (0.30) |
Using Terns Pharmaceuticals hype-based prediction, you can estimate the value of Terns Pharmaceuticals from the perspective of Terns Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Terns Pharmaceuticals using Terns Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Terns using crowd psychology based on the activity and movement of Terns Pharmaceuticals' stock price.
Terns Pharmaceuticals Short Interest
An investor who is long Terns Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Terns Pharmaceuticals and may potentially protect profits, hedge Terns Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 13.1176 | Short Percent 0.1421 | Short Ratio 3.41 | Shares Short Prior Month 12.8 M | 50 Day MA 34.776 |
Terns Relative Strength Index
The Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 34.31 with a mean absolute deviation of 1.36 and the sum of the absolute errors of 80.33.Terns Pharmaceuticals Hype to Price Pattern
Investor biases related to Terns Pharmaceuticals' public news can be used to forecast risks associated with an investment in Terns. The trend in average sentiment can be used to explain how an investor holding Terns can time the market purely based on public headlines and social activities around Terns Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Terns Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Terns Pharmaceuticals.
Terns Pharmaceuticals Implied Volatility | 1.34 |
Terns Pharmaceuticals' implied volatility exposes the market's sentiment of Terns Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Terns Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Terns Pharmaceuticals stock will not fluctuate a lot when Terns Pharmaceuticals' options are near their expiration.
The Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 34.31 with a mean absolute deviation of 1.36 and the sum of the absolute errors of 80.33. Terns Pharmaceuticals after-hype prediction price | USD 33.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Terns contract
Based on the Rule 16, the options market is currently suggesting that Terns Pharmaceuticals will have an average daily up or down price movement of about 0.0838% per day over the life of the 2026-04-17 option contract. With Terns Pharmaceuticals trading at USD 34.45, that is roughly USD 0.0289 . If you think that the market is fully incorporating Terns Pharmaceuticals' daily price movement you should consider acquiring Terns Pharmaceuticals options at the current volatility level of 1.34%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Terns Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Terns Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Terns Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Terns Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Terns Pharmaceuticals' open interest, investors have to compare it to Terns Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Terns Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Terns. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Terns Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Terns price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Terns using various technical indicators. When you analyze Terns charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Terns Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 28th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 34.31 with a mean absolute deviation of 1.36, mean absolute percentage error of 4.28, and the sum of the absolute errors of 80.33.Please note that although there have been many attempts to predict Terns Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Terns Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Terns Pharmaceuticals Stock Forecast Pattern
| Backtest Terns Pharmaceuticals | Terns Pharmaceuticals Price Prediction | Buy or Sell Advice |
Terns Pharmaceuticals Forecasted Value
In the context of forecasting Terns Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Terns Pharmaceuticals' downside and upside margins for the forecasting period are 23.23 and 45.39, respectively. We have considered Terns Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Terns Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Terns Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.065 |
| MAD | Mean absolute deviation | 1.3615 |
| MAPE | Mean absolute percentage error | 0.0458 |
| SAE | Sum of the absolute errors | 80.3298 |
Predictive Modules for Terns Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Terns Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Terns Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Terns Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Terns Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Terns Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Terns Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Terns Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Terns Pharmaceuticals' historical news coverage. Terns Pharmaceuticals' after-hype downside and upside margins for the prediction period are 22.45 and 44.61, respectively. We have considered Terns Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Terns Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Terns Pharmaceuticals is based on 3 months time horizon.
Terns Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Terns Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Terns Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Terns Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.88 | 11.08 | 0.92 | 1.14 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
34.45 | 33.53 | 2.67 |
|
Terns Pharmaceuticals Hype Timeline
Terns Pharmaceuticals is at this time traded for 34.45. The entity has historical hype elasticity of -0.92, and average elasticity to hype of competition of 1.14. Terns is projected to decline in value after the next headline, with the price expected to drop to 33.53. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.67%, whereas the daily expected return is at this time at 2.88%. The volatility of related hype on Terns Pharmaceuticals is about 2797.98%, with the expected price after the next announcement by competition of 35.59. About 83.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.02. Terns Pharmaceuticals had not issued any dividends in recent years. The entity had 1000:50 split on the 4th of November 2013. Given the investment horizon of 90 days the next projected press release will be in about 11 days. Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections.Terns Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Terns Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Terns Pharmaceuticals' future price movements. Getting to know how Terns Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Terns Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TRML | Tourmaline Bio | 0.01 | 4 per month | 0.00 | 0.16 | 6.53 | (2.70) | 58.54 | |
| ORIC | Oric Pharmaceuticals | (0.04) | 11 per month | 3.06 | (0.02) | 6.63 | (4.36) | 15.34 | |
| PGEN | Precigen | 0.30 | 8 per month | 4.59 | 0.05 | 8.52 | (7.08) | 38.64 | |
| IMTX | Immatics NV | (0.13) | 7 per month | 0.00 | (0.02) | 7.31 | (6.47) | 30.34 | |
| ELVN | Enliven Therapeutics | 0.04 | 11 per month | 4.46 | 0.06 | 6.28 | (7.81) | 54.92 | |
| AMLX | Amylyx Pharmaceuticals | 0.08 | 9 per month | 3.00 | (0.01) | 8.11 | (4.94) | 19.81 | |
| NKTR | Nektar Therapeutics | 2.74 | 10 per month | 0.00 | (0.15) | 6.56 | (7.77) | 20.31 | |
| RLAY | Relay Therapeutics | 0.40 | 8 per month | 3.25 | 0.03 | 5.60 | (5.45) | 27.25 | |
| SNDX | Syndax Pharmaceuticals | 0.08 | 10 per month | 2.34 | 0.13 | 8.70 | (3.59) | 18.37 | |
| INBX | Inhibrx Biosciences | 0.48 | 9 per month | 4.23 | 0.11 | 7.03 | (6.08) | 112.80 |
Other Forecasting Options for Terns Pharmaceuticals
For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.Terns Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Terns Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.
Terns Pharmaceuticals Risk Indicators
The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.73 | |||
| Semi Deviation | 2.5 | |||
| Standard Deviation | 10.8 | |||
| Variance | 116.72 | |||
| Downside Variance | 12.74 | |||
| Semi Variance | 6.24 | |||
| Expected Short fall | (7.44) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Terns Pharmaceuticals
The number of cover stories for Terns Pharmaceuticals depends on current market conditions and Terns Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Terns Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Terns Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Terns Pharmaceuticals Short Properties
Terns Pharmaceuticals' future price predictability will typically decrease when Terns Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Terns Pharmaceuticals often depends not only on the future outlook of the potential Terns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Terns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.5 M | |
| Cash And Short Term Investments | 358.2 M |
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.